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Introduction
The capacity to replicate and segregate the entire genome with 
high fidelity is a hallmark of normal division cycles. Furthermore, 
preventing replication of damaged DNA decreases the potential 
for mutations.1 Cellular DNA constantly experiences damage, 
both as a consequence of normal cellular metabolism and respira-
tion, and as a result of environmental insults. In order to cope 
with such genomic damage, cells have evolved a network of DNA 
damage responses (DDR),2 consisting of DNA repair mecha-
nisms, damage tolerance pathways, and cell cycle checkpoints.
Cell cycle checkpoints are systems in place to recognize dam-
aged DNA, or aberrant DNA structures, and activate signaling 
cascades designed to halt or slow progression through the cell 
cycle, thus maximizing the time to repair such damage before 
DNA is replicated or segregated to progeny. Indeed, checkpoint 
failures have been shown to result in chromosomal abnormali-
ties, developmental defects, and predisposition to cancer.3,4 Upon 
sensing damaged DNA, cell cycle checkpoints inhibit progres-




 phases of the cell cycle, while the intra-
S checkpoint slows progression through S phase.4
The intra-S checkpoint can be divided into 2 main signal-
ing cascades that respond to different forms of DNA damage. 
The first recognizes double-strand breaks in DNA, such as those 
induced by ionizing radiation (IR). The intra-S checkpoint 
response to IR requires the proteins ATM, MRE-11, RAD50, 
and NBS1 and involves activation of the checkpoint kinases 
CHK1 and CHK2, promoting proteolytic degradation of 
CDC25A. Loss of the CDC25A phosphatase prevents removal 
of the inhibitory phosphorylation at tyr15 of CDK2, thus main-
taining this kinase inactive, and preventing CDC45 loading and 
initiation at new replication origins.4 ATM also maintains the 
intra-S checkpoint response by signaling through the cohesion 
subunits Smc1 and Smc3.4,5 The second main signaling cas-
cade recognizes bulky DNA adducts, such as those induced by 
UV radiation or benzo[a]pyrene diolepoxide. This checkpoint 
response to UV was found to require the activity of checkpoint 
proteins ataxia telangiectasia and Rad3-related (ATR) kinase, 
and its target CHK1, to act on downstream substrate(s) to 
inhibit the firing of new origins of replication6-8 and to reduce 
the rate of DNA chain elongation.9-11 At sub-lethal f luences of 
UV, the ATR/CHK1 pathway has been shown not to depend on 
degradation of CDC25A, but rather it has been proposed to act 
on the DBF4-dependent kinase to prevent CDC45-dependent 
activation of the MCM helicase, thus inhibiting new replicon 
initiation.12,13
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the AtR/CHK1-dependent intra-S checkpoint inhibits replicon initiation and replication fork progression in response to 
DNA damage caused by UV radiation. It has been proposed that this signaling cascade protects against UV-induced muta-
tions by reducing the probability that damaged DNA will be replicated before it can be repaired. Normal human fibroblasts 
(NHF) were depleted of AtR or CHK1, or treated with the CHK1 kinase inhibitor tCS2312, and the UV-induced mutation 
frequency at the HPRT locus was measured. Despite clear evidence of S-phase checkpoint abrogation, neither AtR/CHK1 
depletion nor CHK1 inhibition caused an increase in the UV-induced HPRT mutation frequency. these results question the 























3556 Cell Cycle Volume 12 Issue 22
It is well established that loss of functional ATM increases 
IR-induced mutation frequency14 and predisposes mammals to 
lymphomas and other malignancies.15 Although ATM is widely 
recognized as a tumor-suppressor gene, it is unclear whether 
this function depends primarily on the activation of the ATM-
dependent intra-S checkpoint or on ATM’s roles in other DNA 
damage responses. In contrast, loss of Atr causes embryonic 
lethality in mice,16,17 while Seckel syndrome is a consequence of 
an ATR hypomorphic splice mutation. Seckel syndrome mani-
fests as a developmental disease, with patients exhibiting dwarf-
ism, microcephaly, and mental retardation, but cancer is not 
typically associated with the disorder.3 Abrogation of the ATR/
CHK1 pathway has clearly been shown to inhibit the intra-S 
checkpoint to UV6,8 and to lead to an increase in chromosomal 
instability.18 Despite these observations, it is less clear whether 
abrogation of the ATR/CHK1-dependent S-phase checkpoint 
influences mutagenesis. To address this question, we employed 
siRNA-mediated depletion of ATR or CHK1, or pharmacologi-
cal inhibition of CHK1 kinase function to inactivate the intra-S 
checkpoint and measured mutation frequency at the HPRT locus 
in UV-irradiated human fibroblasts. The results described here 
support the conclusion that in the presence or absence of the 
rapid activation of intra-S checkpoint responses, UV-irradiated 
normal human fibroblasts acquire the same burden of mutations.
Results
Depletion of ATR or CHK1 abrogated the intra-S phase 
checkpoint triggered by UV
The activation of the intra-S checkpoint in UV-irradiated 
NHF1 was assessed by examining changes in the steady-
state distribution of sizes of nascent DNA pulse-labeled with 
3H-thymidine. Responses were compared in populations pre-
treated with a non-targeted control (NTC) siRNA and those 
with siRNA-mediated depletion of ATR or CHK1. Figure 1A 
illustrates the siRNA-mediated depletion of ATR, which in 
the irradiated cells was accompanied by a severe reduction in 
phosphorylation of its substrate CHK1, a known mediator of 
UV-induced S-phase checkpoint activation.6-8 Velocity sedi-
mentation analyses showed that fibroblasts pre-treated with the 
NTC-siRNA (Fig. 1B) displayed a stereotypical reduction in 
the abundance of small molecular weight (MW) nascent DNA 
when exposed to a low fluence of UVC. The selective reduction 
in abundance of this size class of origin-proximal, newly synthe-
sized DNA represents a functional indicator of the inhibition of 
initiation of replication origins that were scheduled to fire post-
irradiation.8,19,20 Depletion of ATR (Fig. 1C) interfered with this 
selective inhibition of the synthesis of small MW nascent DNA, 
thus demonstrating the abrogation of the intra-S checkpoint 
response of inhibition of replicon initiation. Similarly, inhibition 
of this S-phase checkpoint response was confirmed following 
siRNA-mediated depletion of CHK1 (Fig. 2)
Depletion of ATR or CHK1 did not increase the UV-induced 
mutation frequency at the HPRT locus
Mutation frequency at the HPRT locus was measured in 
NHF1 cells following depletion of ATR or CHK1 and irradiation 
with increasing fluences of UVC (Fig. 3). In cultured fibroblasts 
treated with the NTC-siRNA, UV induced the formation of 
6-thioguanine-resistant mutant colonies at frequencies above the 
background (measured in the sham-irradiated populations) (P < 
0.05 for sham vs. 7.5 J/m2, one-sided Wilcoxon rank-sum test, 
or by linear regression of all fluences). As a pre-validation of the 
adopted methodology, under the laboratory conditions used in 
this study, NHF1 cultures were treated with siRNA targeting the 
trans-lesion synthesis (TLS) DNA polymerase η21; an elevated 
recovery of HPRT mutant colonies was observed, as compared 
with the NTC siRNA-treated population, even at fluences ≤4 
J/m2 (Fig. S1). In contrast, cells depleted of CHK1 or ATR did 
not display mutation frequencies higher than those treated with 
control siRNA (Fig. 3).
Pharmacological inhibition of CHK1 with TCS2312 abro-
gated the UV-induced intra-S phase checkpoint
The results described above were confirmed by experiments 
in which an alternative approach was employed to inactivate the 
intra-S checkpoint. Instead of depleting the cells of the 2 major 
kinases involved in the activation of this checkpoint, a CHK1 
inhibitor (TCS2312) was used to block the signaling pathway 
while retaining normal cellular protein levels. First, the effect of 
increasing concentrations of this inhibitor on overall DNA syn-
thesis rates was measured. The lowest concentrations inhibiting 
DNA synthesis were tested for their effects on the intra-S check-
point response of inhibition of replicon initiation (Fig. S2–4). As 
was observed following depletion of ATR or CHK1, treatment of 
fibroblasts with 1 µM TCS2312 reversed the UV-induced selec-
tive inhibition of small MW nascent DNA observed in the control 
population irradiated with 1 or 2.5 J/m2 UVC, indicating a block-
age in the S-phase checkpoint signaling cascade (Fig. 4; Fig. S4).
CHK1 inhibition did not increase the UV-induced mutation 
frequency at the HPRT locus
Mutation frequencies at the HPRT locus were measured in 
NHF1 cells following treatment with 1 µM TCS2312 and irra-
diation with 0, 2.5, 5, or 7.5 J/m2 UVC (Fig. 5). NHF1 cells 
irradiated in the presence or absence of inhibitor formed 6-thio-
guanine-resistant mutant colonies in a fluence-dependent man-
ner (P < 0.005, linear regression analysis). Despite abrogation of 
the S-phase checkpoint through pharmacological inhibition of 
CHK1, HPRT mutation frequencies were no different than those 
observed in cells not receiving the inhibitor.
Colony-forming efficiency and UV-induced cytotoxicity fol-
lowing ATR/CHK1 depletion or CHK1 inhibition
In the course of performing the mutagenesis studies described 
above, colony-forming assays were done in each experiment 
to assess the effect of siRNA-mediated depletion of CHK1 or 
ATR, or inhibition of CHK1, on overall cell survival and on 
UV-induced cytotoxicity. Depletion of either ATR (P = 0.03, 
one-sided Wilcoxon rank-sum test) or CHK1 (P = 0.01, one-sided 
Wilcoxon rank-sum test) decreased colony-forming efficiency in 
the absence of UV by 63% or 40%, respectively, as compared 
with the colony-forming efficiency of NTC siRNA-treated cells; 
similarly, inhibition of CHK1 by TCS2312 reduced colony-
forming efficiency by 51% compared with the vehicle-treated 
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with TCS2312 (Fig. 6C), also sensitized NHF1 to UV-induced 
cytotoxicity (P < 0.0001 for both siRNA depletions, P < 0.001 for 
inhibitor, by linear regression analysis).
Discussion
Nucleotide excision repair, DNA polymerase η-dependent 
TLS, and cell cycle checkpoints are known to minimize the con-
sequences of UV-induced DNA damage. Xeroderma pigmen-
tosum (XP) is a genetic disorder characterized by dramatic UV 
sensitivity and a >1000-fold predisposition to skin cancers in areas 
exposed to solar radiation.22 XP is primarily caused by mutations 
in nucleotide excision repair genes, highlighting the importance 
of this pathway in protecting against UV-induced mutagenesis 
and carcinogenesis.23 Similarly, XP patients of the variant com-
plementation group (XPV) lack functional DNA polymerase η, 
which is required for efficient synthesis across UV-induced pho-
toproducts.24 XPV patients also display increased sensitivity to 
sunlight, typically developing skin cancers between the ages of 
20 and 30.25 To date it has not been established that aberrant cell 
cycle checkpoints contribute directly to UV-induced carcinogen-





 checkpoints are defective in some melanoma 
cell lines,26-28 but there is no evidence that the intra-S checkpoint 
is abrogated in cancers. The prevailing paradigm has been that 
checkpoints decrease the probability that damaged DNA will be 
replicated, allowing time for nucleotide excision repair to remove 
template lesions. The intra-S checkpoint, in particular, has been 
hypothesized to minimize mutagenesis by inhibiting the replica-
tion of damaged DNA,5 or by improving the efficiency of TLS 
across DNA photoproducts by facilitating PCNA ubiquitina-
tion5,29,30 and recruitment of DNA polymerase η.31,32
Absent or malfunctioning components of the IR-induced DDR 
that regulate cell cycle checkpoint pathways lead to a number of 
human disorders, including ataxia telangiectasia (AT), AT-like 
disorder, Nijmegen breakage syndrome, and Li Fraumeni syn-
drome. Mutations in ATM, NBS1, MRE11, and CHK2 have been 
linked to increased cancer susceptibility, and ATM-deficient cells 
have been shown to be hypermutable in response to IR.14 The 
proteins coded by these genes are involved in multiple facets of 
the IR-induced DDR, including double-strand break repair and 
Figure 1. Depletion of AtR abrogates the intra-S checkpoint response: 
(A)  NHF1 cells were electroporated with NtC or AtR siRNA and 
UV-irradiated (sham or 2.5 J/m2) 48 h following electroporation. Cells 
were harvested and protein extracts examined by immunoblotting 1 
h after irradiation. (B and C) Velocity sedimentation analysis of nascent 
DNA from NHF1 cells exposed to UVC (sham-closed squares or 2.5 J/
m2-open diamonds) 48 h post-electroporation with (B) NtC or (C) AtR 
siRNA; the irradiated cells were incubated for 30 min and then pulse 
labeled with 3H-thymidine for 15 min.
Figure 2. Depletion of CHK1 abrogates the intra-S checkpoint response: 
(A) NHF1 cells were electroporated with NtC or CHK1 siRNA. Cells were 
harvested 24 h later and protein extracts examined by immunoblotting. 
(B and C) Velocity sedimentation analysis of nascent DNA from NHF1 
cells exposed to UVC (sham-closed squares or 2.5 J/m2-open diamonds), 
following electroporation with (B) NtC or (C) CHK1 siRNA. Cells were 
irradiated 24 h post-electroporation and 30 min later were pulse labeled 
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multiple cell cycle checkpoints4; hence, it is not clear if loss of the 
intra-S checkpoint contributes to the increase in susceptibility to 
malignancy. Mutations identified as causing Seckel syndrome, 
either in ATR, ATRIP, or PCNT, result in impaired UV-induced 
DDR,33-35 but elevated cancer risk is not typically associated with 
this disease. It is unclear whether a malfunctioning ATR/CHK1-
dependent intra-S checkpoint results in increased mutation 
frequencies in cells exposed to agents that induce bulky DNA 
lesions (e.g., UV or benzo[a]pyrene diolepoxide). Results shown 
here confirmed that upon depletion of ATR or CHK1 the intra-S 
checkpoint was not activated by UV. Similarly, pharmacologic 
inhibition of the CHK1 kinase abrogated the UV-induced inhi-
bition of replicon initiation. However, the UV-induced muta-
tion frequency at the HPRT locus was not increased relative to 
matched controls. These results suggest that loss of ATR/CHK1 
signaling, at least during the first S phase following UV expo-
sure, when cells must cope with the highest density of DNA 
photoproducts, does not result in higher mutation frequencies, 
even at a locus (HPRT ), where point mutations as well as small 
or large deletions result in the same phenotype (6-thioguanine 
resistance).
To date, little information is available regarding the role of 
the ATR/CHK1 pathway as a tumor suppressor. However, some 
insight can be derived from research describing germline or 
somatic mutations that are presumed to affect this pathway, or 
by examining data from animal models targeting ATR/CHK1. 
A germline mutation in the FAT domain of ATR in an autoso-
mal-dominant oropharyngeal cancer syndrome,36 or a muta-
tion in the checkpoint mediator CLSPN in the germline of a 
familial breast cancer case,37 did not impair intra-S checkpoint 
activation as measured by CHK1 phosphorylation. Somatic 
mutations in ATR and CHK1 have also been reported in endome-
trial, colorectal, and stomach cancers, particularly in mismatch 
Figure 3. Depletion of AtR or CHK1 does not increase UV-induced muta-
tion frequency at the HPRT locus: (A) Depletion of AtR in cells used for 
mutagenesis experiment. NHF1 cells were electroporated with NtC or 
AtR siRNA and irradiated (sham, 2.5, or 5 J/m2) 48 h following electro-
poration. Cells were harvested and protein extracts examined by immu-
noblotting 1 h after irradiation. (B) Depletion of CHK1 in cells used for 
mutagenesis experiment. NHF1 cells were electroporated with NtC or 
CHK1 siRNA. Cells were harvested 24 h later and protein extracts exam-
ined by immunoblotting. (C) UV-induced (0, 2.5, 5, or 7.5 J/m2) HPRT 
mutation frequencies in NHF1 following depletion of AtR (open triangle) 
or CHK1 (closed squares) or NtC (open diamonds) expressed as mutants 
per 106 surviving cells ± SeM. Values for sham or 7.5 J/m2 were slightly 
offset on figure to allow for clear illustration of error bars. In NtC-treated 
cells, UV induced a mutation frequency statistically higher than the 
sham irradiated cells (P < 0.05 for sham vs. 7.5 J/m2, one-sided Wilcoxon 
rank-sum test, or by linear regression of all fluences). Depletion of AtR 
or CHK1 did not cause a significant difference in UV-induced mutation 
frequency (P = 0.86 and 0.63, respectively, Wilcoxon rank-sum test).
Figure  4. CHK1 inhibitor tCS2312 abrogates the intra-S checkpoint 
response: Velocity sedimentation analysis of nascent DNA from NHF1 
cells treated with the CHK1 inhibitor tCS2312. Cells were treated with 
(A) vehicle or (B) 1 µM tCS2312 30 min prior to irradiation with 0 (closed 
squares), 1 (open circles), or 2.5 (closed diamonds) J/m2 UVC and inhibi-
tor remained until cells were harvested. Cells were pulse-labeled with 
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Figure 5. CHK1 inhibitor tCS2312 does not increase UV-induced muta-
tion frequency at the HPRT locus: UV-induced (0, 2.5, 5, or 7.5 J/m2) HPRT 
mutation frequencies in NHF1 following treatment with vehicle (closed 
diamonds) or 1 µM tCS2312 (open squares) expressed as mutants per 
106 surviving cells (n = 2). In both vehicle and tCS2312-treated cells, UV 
induced a fluence-dependent increase in mutation frequency (P < 0.005, 
linear regression analysis). the UV-induced mutation frequency was not 
different between cells treated with vehicle or inhibitor (P = 0.97, linear 
regression analysis).
Figure 6. Influence of AtR or CHK1 depletion, or CHK1 inhibition, on col-
ony-forming efficiency or UV-induced cytotoxicity: (A) Colony-forming 
efficiency of cells depleted of CHK1 (n = 4) or AtR (n = 6), or treated 
with 1 µM tCS2312 (n = 2), as compared with either the NtC (n = 10) 
or vehicle (n = 2) treated cells. Depletion of AtR (P = 0.03, one-sided 
Wilcoxon rank-sum test) or CHK1 (P = 0.01, one-sided Wilcoxon rank-sum 
test) decreased colony-forming efficiency from that of NtC-treated cells. 
(B)  UV-induced cytotoxicity of NHF1 after siRNA-mediated depletion 
of NtC (open diamonds), AtR (open triangles) or CHK1 (closed squares) 
as measured by colony-forming efficiency. Depletion of AtR or CHK1 
increased UV-induced cytotoxicity (P < 0.0001 for both depletions, lin-
ear regression analysis). (C) UV-induced cytotoxicity of NHF1 after treat-
ment with vehicle (closed diamonds), or 1 µM tCS2312 (open squares) as 
measured by colony-forming efficiency. All values n = 2. the UV-induced 
cytotoxicity in cells treated with inhibitor was greater than that of vehi-
cle-treated cells (P < 0.001, linear regression analysis).
repair-deficient cells with microsatellite instability (MSI).38-40 It 
is unclear whether or not these mutations compromise the acti-
vation of the intra-S checkpoint, and whether they are cancer 
drivers or passenger mutations. One MSI+ colon cancer cell line, 
heterozygous for an ATR truncation mutation, was shown to 
be impaired in the UV-induced phosphorylation of CHK1 and 
the late-S/G
2
 arrest induced by topotecan.41 In this same study, 
chronic myelogenous leukemia cells transiently transfected with 
an ATR truncation mutant allele displayed a similar phenotype 
while retaining expression of endogenous ATR, suggesting that 
the truncation mutation acts in a dominant-negative manner. We 
cannot rule out the possibility that a dominant-negative ATR 
or CHK1 could influence UV-induced mutation frequency. 
However, such a mechanism would most likely not depend on 
the inhibition of CHK1 kinase activity, as we did not observe a 
change in UV-induced mutation frequency upon pharmacologi-
cal inhibition of CHK1 kinase.
Animal models for ATR or CHK1 heterozygosity have also 
shown enhanced tumorigenesis17,42-45 or tumor progression.42 The 
reported effects, however, often require synergistic combination 
with a cancer-driver mutation. For example, loss of one allele of 
Chk1 or p53 in mouse mammary tissue did not result in tumor 
formation, but when combined, the loss of one allele at each locus 
resulted in 60% tumor formation.46 Similarly, Atr+/−, Mlh−/− 
mice developed cancer at much higher rates (71%) than their 
Atr+/− (0%) or Mlh−/− (17%) littermates.44 It is known that 
Atr- and Chk1-knockout mice are not viable16,17,45 and that loss of 
either protein enhances cytotoxicity; therefore, the tumorigenic 
effects described above might depend on a threshold of expres-
sion of these proteins. The implications to our findings would 
be that below this threshold, cell survival is compromised to the 
point that enhanced mutagenesis may not be observed in our in 
vitro system. It has yet to be determined if moderately depleted 
levels of ATR or CHK1, such as those observed in heterozygous 
knockout animals, would allow cell survival at the cost of 
genomic instability and increased mutagenesis.
There is evidence that intra-S checkpoint signaling affects 
TLS,29,31,32,47 and it is conceivable that intra-S checkpoint inhi-
bition is also inhibiting efficient TLS. Because mutagenesis 
requires replication of the damaged DNA, error-prone TLS is 
considered a prominent driver of UV-induced mutagenesis. Thus, 
even if intra-S checkpoint inhibition was allowing newly fired 
replication forks to encounter UV-induced DNA damage sites, 
TLS would be required to replicate across the photolesions and 
to potentially induce mutations. If ATR or CHK1 were impor-
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checkpoint functions), it stands to reason that the depletion of 
these enzymes might inhibit TLS and reduce mutation frequency. 
It has been suggested that ATR, CHK1, and other components 
of the replication fork protection complex not only participate in 
the activation of the intra-S checkpoint, but also possess separate 
functions for preservation of intrinsic chromosomal stability,18 
particularly at common fragile sites.48,49 Common fragile sites 
tend to be replicated late in S phase; the formation of secondary 
structures within the fragile sites is thought to slow progression 
of replication forks.49,50 It is of note that the active HPRT gene 
is replicated early in S phase.51 Perhaps the primary function of 
the intra-S checkpoint proteins is to preserve genomic stability 
at difficult to replicate regions and/or regions replicated late in 
S-phase, and that inhibition of replicon initiation in response to 
UV is not of primary importance in minimizing UV-induced 
mutations in regions of the genome that are replicated more easily 
or early in S phase.
The results reported here show that severe depletion of ATR/
CHK1 did not increase UV-induced mutagenesis, perhaps as a 
consequence of preferential cytotoxicity in cells most depleted 
of CHK1 or ATR or decreased TLS efficiency. There has been 
increasing interest in developing ATR or CHK1 kinase inhibi-
tors as therapeutics designed to sensitize cancer cells to the cyto-
toxic effects of clinical drugs.52 Our results agree with many 
others showing that CHK1 inhibition sensitizes cells to DNA 
damaging agents, including cisplatin in non-small cell lung 
carcinoma cells53 and camptothecin in colon cancer cells.54 An 
attractive idea has been that some cancer cells are selectively 
sensitive to ATR/CHK1 inhibition in combination with DNA 
damaging agents, perhaps because of loss of the p53-dependent 
G
1
 checkpoint.55 Although our results indicate that loss of ATR/
CHK1 or inhibition of CHK1 does not increase UV-induced 
mutagenesis, it remains to be determined if this would hold true 
for other DNA-damaging chemotherapeutics. If so, our results 
would suggest that the combination of ATR/CHK1 inhibitors 
and chemotherapy would have the additional advantage of not 
enhancing the probability of drug-resistant clones or secondary, 
chemotherapy-induced cancers emerging from an increase in 
mutagenesis.
Materials and Methods
Cell culture and UV treatment
The normal human fibroblast cell line NHF1-hTERT was 
derived from neonatal foreskin fibroblasts56 and immortalized by 
ectopic expression of the catalytic subunit of human telomerase.6 
Cells were cultured in minimum essential medium (GIBCO) 
supplemented with 10% fetal calf serum and 2 mM L-glutamine, 
and were maintained in humidified 95% air and 5% CO
2
 at 37 
°C. For UV irradiations, cells were rinsed in phosphate buffered 
saline, all extra liquid removed, and the culture plates irradiated 
without the lids. Irradiation was performed with a fluorescent 
germicidal lamp emitting primarily 254 nm UVC (Sylvania 
G8T5, 90% emission at 254 nm). Control plates were treated 
under identical conditions, but were not exposed to UV (sham 
controls). Lamp irradiance was measured using a UVX Digital 
Radiometer (Ultra-Violet Products, Inc.) using the UVX-25 sen-
sor (250–290 nm range, calibrated at 254 nm).
Protein depletion
siRNA was introduced by electroporation (100 pmol siRNA 
per 106 cells), using the normal human dermal fibroblast kit 
VDP-1001 (Lonza) and program U-23 on a Nucleofector 2b elec-
troporation device (Lonza). ON-TARGET plus duplex siRNAs 
were purchased from Dharmacon: NTC (D-001210-2), CHK1 
(J-003255), and ATR SMART pool (L-003202). Experiments 
were conducted 24 h post-electroporation with CHK1 or 48 h 
post-electroporation with ATR.
CHK1 inhibitor TCS2312
The CHK1 inhibitor TCS2312 (Tocris) was dissolved in ster-
ile water (1 mM stock solution) and added to cell culture medium 
at the indicated concentrations. For velocity sedimentation exper-
iments, inhibitor was added 30 min prior to irradiation and kept 
in the medium during the subsequent 30 min incubation and 
the 15 min 3H-thymidine pulse-labeling period. For mutagenesis 
and cytotoxicity experiments, inhibitor was added 30 min prior 
to irradiation and removed 6 h after the UV exposure, at which 
time the cells were rinsed with buffered saline and fed with fresh 
culture medium.
Western blotting and antibodies
One hour after irradiation, cells were harvested by trypsiniza-
tion, pelleted, and flash frozen in liquid nitrogen. Frozen pellets 
were resuspended in lysis buffer (8 M urea, 5 M NaH2PO4, 1 
M Tris-HCl pH 8) on ice for 30 min and then clarified by cen-
trifugation (16 000 × g and 4 °C). The Bio-Rad Protein Assay 
kit was used to determine protein concentration. Equal volumes 
of loading buffer (125 mM Tris pH 6.8, 20% glycerol, 10% 
β-mercaptoethanol, 4% sodium dodecyl sulfate, 0.05% bromo-
phenol blue) were combined with protein lysates and samples 
were boiled for 5 min. Equal amounts of protein were loaded 
onto BioRad Criterion-TGX 4–15% gradient gels (approxi-
mately 150–200 V, 2–4 h). Size-separated proteins were trans-
ferred overnight (100 mA) onto a nitrocellulose membrane. After 
blocking in 5% powdered milk in TBST (0.5% Tween-20, 10 
mM Tris-HCl pH 7.4, 10 mM NaCl), primary antibodies were 
applied. The following antibodies were used: rabbit anti-P-CHK1 
S345 (Cell Signaling, 2348), mouse anti-CHK1 (Santa Cruz, 
sc-8408), goat anti-ATR (Santa Cruz, sc-1887), and goat anti-
Actin (Santa Cruz, sc-1616). Following application of secondary 
antibody conjugated with horseradish peroxidase (Amersham), 
bands were visualized on film by enhanced chemiluminescence 
(ECL). An Alpha Innotech Fluor-Chem HD2 was used to mea-
sure the densitometry of film bands.
Velocity sedimentation
As previously described,19,57 the steady-state size distribution 
of nascent DNA was determined by centrifugation in an alkaline 
sucrose density gradient 45 min after UV irradiation. Cells were 
uniformly pre-labeled during logarithmic growth by incubation 
with 14C-thymidine (5–10 nCi/mL) for at least 36 h. Medium 
containing 14C-thymidine was removed overnight and cells 
treated the following day. Thirty minutes after UV-irradiation, 
cells were incubated with 25 µCi/mL 3H-thymidine for 15 min. 
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0.01 M EDTA (pH 8) and then passed through a 22G needle 
5×. An equal volume of cell suspension was added to 0.5 mL 
of lysis buffer (1 M NaOH, 0.02 M EDTA) already on top of 
an alkaline sucrose gradient (5–20% sucrose in 0.4 M NaOH, 2 
M NaCl, 0.01 M EDTA). These gradients were left under fluo-
rescent lighting for 45 min and then centrifuged in a Beckman 
SW32Ti rotor for 5 h at 25 000 rpm and 20 °C. Gradients were 
fractioned through a hole punctured in the bottom of the cen-
trifuge tube and acid-precipitable material filtered onto glass 
microfiber filters (Whatman GF/C 24 mm). The glass microfi-
ber filters were then analyzed by liquid scintillation counting. All 
experiments included cells pre-labeled with 14C-thymidine but 
not pulse-labeled with 3H-thymidine. These samples were used to 
measure the 14C CPM values detected in the 3H channel during 
liquid scintillation counting. Normalized 3H CPM were the 3H 
CPM in each fraction, corrected for the 14C spillover, and divided 
by the total 14C in the gradient (proportional to the number of 
added cells).
HAT selection
Pre-selection for functional HPRT in cells used for mutagene-
sis experiments was performed by expanding cultures in medium 
supplemented with 1× HAT (100× lyophilized HAT contains 
10 mM sodium hypoxanthine, 40 M aminopterin, and 1.6 mM 
thymidine) for 10–14 d.58 A new aliquot of frozen and stored 
HAT selected cells was used in each HPRT mutagenesis experi-
ment. Cell cultures were expanded in normal medium without 
HAT for 10–14 d prior to any treatment.
Cytotoxicity experiments
Concurrent with the mutagenesis experiments, cytotoxicity 
was determined by colony-forming assay at the time of treatment. 
Cells depleted of CHK1 (and their matched NTC controls) were 
plated at a density of 1000 cells per 10-cm dish and irradiated 
24 h after electroporation. Cells depleted of ATR (and their 
matched NTC controls) were placed in culture for 24 h post-
electroporation and re-seeded at a density of 500 cells per 10-cm 
dish and irradiated 48 h after electroporation. Cells to be treated 
with 1 µM TCS2312 or vehicle (sterile water) were seeded at a 
density of 500 cells per 10-cm dish and the inhibitor or vehicle 
added 30 min prior to irradiation (24 h post-electroporation). 
The inhibitor remained on the cultures for 6 h post-irradiation. 
The selected cell densities resulted in approximately 100 colonies 
per dish for the vehicle or NTC-treated, sham-irradiated plates, 
and 3–6 plates per condition were counted. Cells were fed weekly 
and colonies fixed in 3:1 methanol:acetic acid and stained with 
0.05% crystal violet approximately 2 wk later. Colonies with 
more than 50 cells were counted.
Mutagenesis
Mutagenesis experiments were started by plating electropor-
ated cells at 1 × 106 per dish or 5 × 105 for cells to be treated with 
vehicle/inhibitor (2 plates per condition). Cells were irradiated 
24 h (CHK1) or 48 h post-electroporation (ATR). In the inhibitor 
experiments, 1 µM TCS2312 or an equal volume of sterile water 
was added 30 min before and removed 6 h after the cells were irra-
diated (24 h after plating). Cells were maintained in logarithmic 
growth for 4–6 population doublings before HPRT mutants were 
selected by plating 4 × 104 cells per 10-cm dish (55 dishes per 
treatment) in medium containing 40 µM 6-thioguanine. At the 
time of selection, colony-forming efficiency was determined by 
plating 400 cells per dish in medium lacking 6-thioguanine. 
Approximately 2 wk post-seeding, colonies in all plates were fixed 
in 3:1 methanol:acetic acid and stained with 0.05% crystal vio-
let, and those with more than 50 cells were counted. Mutation 
frequencies were calculated from the number of plates without 
any mutant colonies, using the Poisson distribution as follows: 
(-ln [number of plates without 6-thioguanine resistant colonies/
total number of plates])/([number of cells plated for selection] × 
[colony-forming efficiency at time of selection]).
Statistical methods
Statistical comparisons were performed in order to determine 
whether UV-induced mutation frequencies, UV-induced cyto-
toxicity, or colony-forming efficiency following siRNA-mediated 
depletion of ATR or CHK1, or pharmacological inhibition of 
CHK1, varied significantly from the NTC or vehicle controls. 
The linear regression model was used to carry out data analy-
sis for estimating various parameters of interest with appropriate 
95% confidence intervals and hypothesis testing. Specifically, 
the linear model was used to model the mutation frequency and 
cell survival percentage as response variables, using UVC fluence 
level and siRNA-mediated protein depletion or inhibitor treat-
ment as covariates. The interaction effect between covariates was 
also considered to make the model more flexible. Wald statistics 
were used to determine the statistical significance of the com-
parisons. The Wilcoxon rank sum test was used to do group-
wise comparisons at different UVC fluences and with different 
protein depletions to test for statistical differences in mutation 
frequency or colony-forming efficiency. Exact test statistics were 
used to determine the statistical significance of the compari-
sons. All statistical analyses were performed using SAS 9.3 (SAS 
Institute Inc).
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